Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer

Summary

The purpose of this study is to determine whether talactoferrin can improve overall survival in patients with non-small cell lung cancer (NSCLC) who have been previously treated with two or more regimens.

Timeline

Start

2008-11

Primary completion

2011-03

Completion

2012-08

Drugs

Indications